Merck & Co. Other Noncash Income (Expense) increased by 83.1% to -$20.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 81.7%, from -$109.00M to -$20.00M. Over 3 years (FY 2021 to FY 2025), Other Noncash Income (Expense) shows an upward trend with a -11.3% CAGR.
Large fluctuations may indicate one-time accounting adjustments or non-recurring non-cash events that require further investigation.
This category aggregates various non-cash items that do not fit into standard categories like depreciation or stock-base...
Standard line item in cash flow statements; peers use this to capture miscellaneous non-cash accounting impacts.
operating_other_noncash_income_expense| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$92.00M | -$171.00M | -$306.00M | -$143.00M | -$656.00M | -$370.00M | -$132.00M | $197.00M | -$202.00M | $86.00M | -$436.00M | -$83.00M | -$91.00M | -$437.00M | -$109.00M | -$335.00M | $0.00 | -$118.00M | -$20.00M |
| QoQ Change | — | -85.9% | -78.9% | +53.3% | -358.7% | +43.6% | +64.3% | +249.2% | -202.5% | +142.6% | -607.0% | +81.0% | -9.6% | -380.2% | +75.1% | -207.3% | +100.0% | — | +83.1% |
| YoY Change | — | — | — | — | -613.0% | -116.4% | +56.9% | +237.8% | +69.2% | +123.2% | -230.3% | -142.1% | +55.0% | -608.1% | -31.3% | -268.1% | +100.0% | — | +81.7% |